While in the clinical trial expertise with Xyrem in narcolepsy/cataplexy individuals at therapeutic doses, two people documented stress and 1 described sleeplessness next abrupt discontinuation on the termination of your medical demo; in the two individuals with stress, the frequency of cataplexy ex